Cardiac Amyloidosis Registry of University Hospital Leipzig
ConditionCardiac Amyloidosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Leipzig
About this trial
This is a clinical registry of patients with cardiac amyloidosis being treated at University Hospital Leipzig. The aim of the registry is to collect detailed information about clinical events, symptoms, imaging, biomarkers, comorbidities, and treatment from routine patient management which would not be provided by randomized clinical trails.
Eligibility criteria
Qualifiers
Confirmed cardiac amyloidosis according to current standards
Disqualifiers
refusal to participate
Trial design
Treatments tested in this trial
- Routine diagnostics
- Routine treatment
Treatment groups
500 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov